Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

Outbreaks of emerging infections present health professionals with the unique challenge of trying to select appropriate pharmacologic treatments in the clinic with little time available for drug testing and development. Typically, clinicians are left with general supportive care and often untested c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dyall, Julie, Coleman, Christopher M., Hart, Brit J., Venkataraman, Thiagarajan, Holbrook, Michael R., Kindrachuk, Jason, Johnson, Reed F., Olinger, Gene G., Jahrling, Peter B., Laidlaw, Monique, Johansen, Lisa M., Lear-Rooney, Calli M., Glass, Pamela J., Hensley, Lisa E., Frieman, Matthew B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2014
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4136000/
https://ncbi.nlm.nih.gov/pubmed/24841273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03036-14
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak